Cathie's Ark Logo
undefined Logo

ARKK Holdings of Verve Therapeutics (VERV) - Updated Daily

Gene TherapyGenomicsCRSPR Gene Editing
Morning Brew Icon
China's One Ocean Problem
Date
Direction
Shares
Fund Weight
Fund
July 3, 2024
SELL52.668k0.0044%ARKK
July 2, 2024
SELL106.149k0.0088%ARKK
July 1, 2024
SELL93.000ARKK
June 25, 2024
SELL7.032k0.0006%ARKK
June 10, 2024
SELL124.646k0.0104%ARKK

Key Statistics

⚖️Weighting🧢Market Cap
0%$431.58m
🏋🏿‍♂️Weight Rank In ARKK🌏Country
35🇺🇸United States
🏋️‍♀️Weight Rank Across All Funds💳ARK Estimated Cost Average
209$28.17
🎫ARK Ownership Percent
0.06%

Other ETFs That Hold VERV

Ticker
NameWeight
ARKGARK Genomic Revolution ETF2.46%
GNOMGlobal X Genomics & Biotechnology ETF1.1%
XBISPDR® S&P Biotech ETF0.82%
ARKKARK Innovation ETF0.36%
LABUS&P Biotech Bull 3X Shares ETF0.124%
IBBiShares Biotechnology ETF0.07%

Research Notes and Commentary for VERV

No Research Notes Found for VERV